Showing results (1231-1240 of 1,437) with videos related to

Sort By:
Pageof 144
European Urology|August 14, 2022
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract TumorsGeorge J Netto, Mahul B Amin, Daniel M Berney, et al.
NAR Cancer|June 6, 2022
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assayFrancesco Orlando, Alessandro Romanel, Blanca Trujillo, et al.
European Urology|October 6, 2022
Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization ClassificationGeorge J Netto, Mahul B Amin, Eva M Compérat, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 27, 2010
Testing mutual exclusivity of ETS rearranged prostate cancerMaria A Svensson, Christopher J LaFargue, Theresa Y MacDonald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United StatesJuan-Miguel Mosquera, Rohit Mehra, Meredith M Regan, et al.
Cells|June 25, 2020
Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond <i>SMARCA4</i> Mutations: A Comprehensive Genomic AnalysisAurélie Auguste, Félix Blanc-Durand, Marc Deloger, et al.
Cancer Research|June 3, 2004
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancerMark A Rubin, Sooryanarayana Varambally, Rameen Beroukhim, et al.
Cancer Research|September 5, 2006
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancerSven Perner, Francesca Demichelis, Rameen Beroukhim, et al.
Neuropharmacology|June 25, 2013
A novel, potent, oral active and safe antinociceptive pyrazole targeting kappa opioid receptorsGabriela Trevisan, Mateus F Rossato, Cristiani I B Walker, et al.
The Journal of Clinical Investigation|December 5, 2017
Differential impact of RB status on E2F1 reprogramming in human cancerChristopher McNair, Kexin Xu, Amy C Mandigo, et al.
Pageof 144